Project Grant R01DA063973
Award Date 5/15/26
Completion Date 2/28/31
Dollars Obligated $778K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, USA
Similar Awards
- Federal Project Grant Award Summary New York University School of Medicine received a $2.09M project grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded July 1, 2025, with completion targeted for March 31, 2030. This research initiative characterizes complex Opioid Use Disorder (OUD) care trajectories and outcomes following acute service utilization through a population-based data linkage study. The project applies...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Columbia University's Health Sciences Division a $1.49M Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) beginning September 15, 2025, with completion targeted for May 31, 2030. This research initiative will conduct a longitudinal investigation of Veterans Health Administration (VHA) patient data to examine the relationship between cannabis use disorder (CUD) and opioid-related health outcomes....
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.5 million Project Grant to the University of Massachusetts Medical School on September 1, 2025, to conduct the "Improving Access to Medications for Opioid Use Disorder (MOUD) in Drug Courts Through Inter-Agency Collaboration: COLAAB Study" under the Drug Use and Addiction Research Programs (CFDA 93.279). The five-year project, concluding May 31, 2030, implements and evaluates a package of...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $159,615 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2025, for research extending through June 30, 2027. This K99/R00 award supports a research initiative titled "Predicting Craving and Relapse Using Neurobehavioral Markers of Goals and Habits in Opioid Use Disorder." The project delivers longitudinal neurobehavioral...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a Project Grant totaling $787,594 under the Drug Use and Addiction Research Programs (CFDA 93.279) for research on the cortical mechanisms of opioid reinforcement. The award, effective September 1, 2025, through May 31, 2030, supports a comprehensive research program investigating the molecular, cellular, and circuit-based mechanisms underlying opioid use disorder...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Icahn School of Medicine at Mount Sinai a $1,517,762 Project Grant (CFDA 93.279: Drug Use and Addiction Research Programs) effective July 1, 2025, through March 31, 2030. The award supports research leveraging integrative computational modeling and artificial intelligence-based tools to develop safer opioid therapeutics. The research addresses the critical public health challenge of opioid misuse and overdose...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a Project Grant totaling $1,541,806 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct the STRONG (Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV) study. Effective from August 1, 2025 through April 30, 2030, this research initiative will comprehensively characterize opioid use...
- The federal Project Grant award with ID DP2DA062283 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The $2,542,500 grant, awarded on September 1, 2024, will support the development of novel econometric methods and a unified framework for integrating real-world evidence (RWE) to analyze inconclusive randomized controlled trials (RCTs) focused on opioid use disorder (OUD) treatments. The project, to be conducted by Weill...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded University of Colorado-Denver a Project Grant of $709,085 under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct an implementation trial examining in-hospital opioid treatment program (OTP) intake facilitation. The project, awarded April 1, 2026 with a completion date of January 31, 2031, will implement a series of evidence-based implementation facilitation activities across four hospitals to...
- Federal Grant Award Summary The National Institute on Drug Abuse awarded $399,600 through its Drug Use and Addiction Research Programs (CFDA 93.279) to support a Mentored Research Scientist Development Award (K01) focused on developing dynamic treatment regimes for personalized opioid use disorder care. Awarded on August 15, 2025, with a completion date of July 31, 2030, this five-year career development and research initiative is led by Dr. Jason Brian Gibbons at the University of Colorado...